Tuberculosis Vaccine in Healthy Indian Adults
- Conditions
- Tuberculosis
- Interventions
- Biological: Tuberculosis Vaccine
- First Posted Date
- 2024-06-03
- Last Posted Date
- 2024-06-03
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 30
- Registration Number
- NCT06438978
- Locations
- 🇮🇳
NIMS, Hyderabad, Hyderabad, Telangana, India
The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants
- Conditions
- Rotavirus Infection of Children
- Interventions
- Biological: ROTAVAC 5DOther: Placebo
- First Posted Date
- 2024-01-11
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 5800
- Registration Number
- NCT06200844
- Locations
- 🇨🇱
CESFAM Esmeralda, Santiago, Chile
🇨🇱CESFAM Colina, Santiago, Chile
🇨🇱Hospital de ninos Roberto del Rio, Santiago, Chile
To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131)
- Conditions
- Cholera
- Interventions
- Biological: Hillchol vaccine
- First Posted Date
- 2023-02-17
- Last Posted Date
- 2023-02-17
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 1800
- Registration Number
- NCT05732766
- Locations
- 🇮🇳
King George Hospital, Visakhapatnam, Visakhapatnam, Andhra Pradesh, India
🇮🇳Rajarajeswari Medical College and Hospital, Kambipura, Bangalore, India
🇮🇳All India Institute of Medical Sciences, Patna, Patna, Bihar, India
BBV152/BBV154 Heterologus Prime-Boost Study
- Conditions
- Corona Virus Infection
- Interventions
- Biological: COVAXIN(BBV152)Biological: BBV154 Intranasal Vaccine
- First Posted Date
- 2022-12-07
- Last Posted Date
- 2022-12-07
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 608
- Registration Number
- NCT05639998
- Locations
- 🇮🇳
The INCLEN Trust International/Guru Nanak Hospital, Gurgaon, Haryana, India
🇮🇳JSS Medical College & Hospital, Mysore, Karnataka, India
🇮🇳Institute of Medical Sciences and SUM Hospital,Odisha, Bhubaneswar, Odisha, India
Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose
- Conditions
- COVID-19 Respiratory Infection
- Interventions
- Biological: BBV154 Intranasal VaccineBiological: Intramuscular vaccine COVAXINBiological: Covishield
- First Posted Date
- 2022-10-05
- Last Posted Date
- 2022-10-05
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 875
- Registration Number
- NCT05567471
- Locations
- 🇮🇳
ESIC Medical College and Hospital, Faridabad, Haryana, India
🇮🇳St. Theresa Hospital, Hyderabad, Telangana, India
🇮🇳All India Institute of Medical Sciences, Patna, Bihar, India
Phase III Study of BBV154 Intranasal Vaccine in Healthy Volunteers
- Conditions
- COVID-19 Respiratory Infection
- Interventions
- Biological: BBV154(Intranasal) & covaxin
- First Posted Date
- 2022-08-31
- Last Posted Date
- 2022-08-31
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 3160
- Registration Number
- NCT05522335
- Locations
- 🇮🇳
AIIMS (All India Institute of Medical Sciences), Patna, Bihar, India
🇮🇳Redkar Hospital and Research center, Dargalim, Goa, India
🇮🇳Oyster and Pearl Hospitals (Phadnis Clinic Pvt Ltd), Pune, Maharashtra, India
A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131).
- Conditions
- Cholera
- Interventions
- Biological: Hillchol vaccineBiological: Shanchol Vaccine
- First Posted Date
- 2022-08-18
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 1800
- Registration Number
- NCT05507229
- Locations
- 🇮🇳
King George Hospital,Visakhapatnam, Visakhapatnam, Andhra Pradesh, India
🇮🇳Pt BD Sharma,PGIMS/UHS. Rohtak, Rohtak, Haryana, India
🇮🇳All India Institute of Medical Sciences,Patna, Patna, Bihar, India
COVAXIN in a Pediatric Cohort
- Conditions
- SARS-CoV2 Infection
- Interventions
- Biological: COVAXIN
- First Posted Date
- 2021-06-09
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 525
- Registration Number
- NCT04918797
- Locations
- 🇮🇳
Victoria Government Hospital, Visakhapatnam, Andhra Pradesh, India
🇮🇳All India Institute of Medical Sciences, Patna, Bihar, India
🇮🇳Meditrina Institute of Medical Sciences, Nagpur, Maharashtra, India
To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavirus
- Conditions
- Rotavirus Gastroenteritis
- Interventions
- Biological: ROTAVAC 5C -F1Biological: ROTAVAC 5C -F2Biological: ROTAVAC®
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2021-03-29
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 1975
- Registration Number
- NCT04819412
Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19
- Conditions
- SARS-CoV Infection
- Interventions
- Biological: BBV154 VaccineBiological: Placebo
- First Posted Date
- 2021-02-12
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- Bharat Biotech International Limited
- Target Recruit Count
- 175
- Registration Number
- NCT04751682
- Locations
- 🇮🇳
AIIMS,Patna, Patna, Bihar, India
🇮🇳Gillurkar Multispeciality Hospital,Nagpur, Nagpur, India
🇮🇳St.Theresa Hospital, Hyderabad, Hyderabad, India